Pharmaceutical

Market Data & Insights

• Sales data on over 69,000 pipeline drugs and 126,000 marketed drugs globally, including over 6,600 drugs analyst consensus sales and forecasts entered within 24 hours of release
• Regulatory Milestones Tracker providing interactive search for drug expiries and reviews designations in the US, EU and Japan
• Coverage of 345,000 Trials (covering rare and niche diseases) – includes observational studies, in addition to interventional and expanded access
• 468,000 clinical Investigators globally, with enrolment data on more than 500 diseases and Trial Sites
• In-depth disease analysis and forecasts on more than 120 disease markets — spanning rare and niche indications and large, well-established markets.
• Expert analysis of disease populations, annualized forecasts of incident and/or prevalent cases (total or diagnosed) with multiple parameters
• Pricing and Market Access for drug pricing, reimbursement and market access strategies, along with forecasting and analytical tool for up-to-date global outlook for 70 markets.

Investigative News

• Exclusive, hard-hitting, investigative reporting on pipeline drugs as well as intelligence for contract research organizations
• Focus is on uncovering business-critical information that has not been publically divulged and providing nuanced, forward-looking analyses on market-moving healthcare topics
• Reporting is based on talking to Key Opinion Leaders and others with first-hand expertise as well as C-level executives
• Drug Insights helps subscribers conduct due diligence and assess risk on drug candidates ahead of high-impact events such as trial readouts, approvals and market launches
• Outsourcing Insights provides actionable information to help CROs secure new business and gain intel on their competitors
• Content is also available via Real-Time Alerts as well as Daily and Weekly recap emails

Themes

• A single, integrated thematic research platform that provides an easy-to-use framework for tracking all themes across all companies in all sectors
• A theme map which monitors the disruptive impact of the top 30 to 40 themes in the sector
• A tool to help senior executives protect their blindside, predict their industry’s future and benchmark their competitors against disruptive threats

Company Intelligence

• Insight on ~250,000 clinical trials from Phase 0 to IV covering all diseases (including rare and niche diseases)
• Track over 50,000 pipeline drugs and 85,000 marketed drugs globally, including country market size, market access and regulatory issues, and key players
• Expert-curated assessments on over 1,100 companies, including Strengths, Weaknesses, Opportunities, and Threats analysis on key players
• Track more than 100,000 companies globally across the pharmaceutical industry value chain

Innovation

• Focus on commercial epidemiology – deeply segmented populations by both new and emerging patient attributes, enabling precise forecasting for niche subpopulations.
• Determine clinical development success rates by Therapy Area, Indication and Molecule Type using Likelihood of Approval and Phase Transition Success Rate tools.
• Identify Sites and Investigators based on their clinical trials experience, ongoing and planned trials, geography and much more
• Benchmark how digital tools are being used to engage patients using Digital Market Intelligence, the industry’s only syndicated digital intelligence offering

Real-time Intelligence

News

• Over 35,000 news alerts every year for an up-to-date view of the latest competitor landscape, including exclusive investigative journalism
• Real-time sentiment analysis of the Top-100 global “Influencers” in the Pharmaceutical Industry
• In-depth coverage of more than 50 international conferences in the US, Europe and Asia.

Deals

• Database of more than 85,000 M&A, strategic alliances and financial transactions for a comprehensive view of investments opportunities
• Real-time monitoring of M&A activity, Strategic Alliances, Capital Raising and Grants, with over 7,000 new deals identified and profiled each year

Analyst Engagement

• Unlimited “Ask an Analyst” functionality with 24-48 hour response time to accelerate decision making